Replay available

ADC Therapeutics SA (ADCT) Q1 2026 Earnings Call

ADC Therapeutics SA (NYSE: ADCT) Q1 2026 earnings conference call, held 2026-05-04. Replay captured from the company's public earnings webcast.

Mon, May 4, 2026 at 8:30 AMendedReplay
ADC Therapeutics SA (ADCT) Q1 2026 Earnings Call

Hosted by

Featured presenters

Nicole Reilly

Head of Investor Relations and Corporate Communications

Amit Malik

Chief Executive Officer

Pepe Carmona

Chief Financial Officer

Maury Raycroft

Jefferies

Michael Schmidt

Guggenheim

Eric Schmidt

Cantor

Sudan Logothan

Stephens

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Adc Therapeutics Sa.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a0425d-5eeb-7ef1-bf99-9539940d2573 Created: 2026-08-27T08:36:53.518Z Duration: 1738.8931 Channels: 1 00:06:58.875 -- 00:07:01.275 Good morning, ladies and gentlemen, and welcome to 00:07:01.275 -- 00:07:04.794 the ADC Therapeutics Q1 twenty twenty six Earnings 00:07:04.794 -- 00:07:05.915 Conference Call. 00:07:06.235 -- 00:07:08.074 At this time, all lines are in listen 00:07:08.074 -- 00:07:10.990 only mode. Following the presentation, we will conduct 00:07:10.990 -- 00:07:12.750 a question and answer session. 00:07:19.150 -- 00:07:22.270 This call is being recorded on Monday, 05/04/2026. 00:07:22.735 -- 00:07:24.175 I would now like to turn the conference 00:07:24.175 -- 00:07:26.895 over to Nicole Reilly, Head of Investor Relations 00:07:26.895 -- 00:07:28.495 and Corporate Communications. 00:07:28.815 -- 00:07:29.855 Please go ahead. 00:07:32.414 -- 00:07:33.775 Thank you, operator. 00:07:34.095 -- 00:07:36.574 Today, we issued a press release announcing our 00:07:36.574 -- 00:07:39.280 first quarter twenty twenty six financial results and 00:07:39.280 -- 00:07:40.400 business updates. 00:07:40.800 -- 00:07:42.800 This release and the slides we will use 00:07:42.800 -- 00:07:45.600 in today's presentation are available on the Investors 00:07:45.600 -- 00:07:48.400 section of the ADC Therapeutics website. 00:07:49.440 -- 00:07:51.680 I'm joined on today's call by our Chief 00:07:51.680 -- 00:07:54.905 Executive Officer, Amit Malik, who will discuss our 00:07:54.905 -- 00:07:57.865 operational performance and recent business highlights, 00:07:58.025 -- 00:08:01.385 followed by our Chief Financial Officer, Pepe Carmona, 00:08:01.385 -- 00:08:03.465 who will review our first quarter twenty twenty 00:08:03....